{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:09:00Z","timestamp":1768871340708,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003693","name":"KIST Institutional programs","doi-asserted-by":"publisher","award":["2E28010"],"award-info":[{"award-number":["2E28010"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008783","name":"National Research Council of Science & Technology","doi-asserted-by":"publisher","award":["CAP-12-1-KIST"],"award-info":[{"award-number":["CAP-12-1-KIST"]}],"id":[{"id":"10.13039\/501100008783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"MEST","doi-asserted-by":"publisher","award":["2013R1A2A2A01068964"],"award-info":[{"award-number":["2013R1A2A2A01068964"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"Korean National Research Foundation","doi-asserted-by":"publisher","award":["2015R1A3A2066619"],"award-info":[{"award-number":["2015R1A3A2066619"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"KIST Graduate School of Science and Technology program","award":["R1435283"],"award-info":[{"award-number":["R1435283"]}]},{"DOI":"10.13039\/501100003693","name":"KIST Institutional Grant","doi-asserted-by":"publisher","award":["2E26860"],"award-info":[{"award-number":["2E26860"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health & Welfare","doi-asserted-by":"publisher","award":["HI11C21100200"],"award-info":[{"award-number":["HI11C21100200"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry & Energy","doi-asserted-by":"publisher","award":["10050154"],"award-info":[{"award-number":["10050154"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"the Korean government (MSIP)","doi-asserted-by":"publisher","award":["2015M3C7A1028926"],"award-info":[{"award-number":["2015M3C7A1028926"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.03.055","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T22:09:14Z","timestamp":1521842954000},"page":"186-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents"],"prefix":"10.1016","volume":"151","author":[{"given":"Seokmin","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Moo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borami","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Elkamhawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sora","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinpyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ha","family":"Paek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Justin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed H.E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Soo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-3451","authenticated-orcid":false,"given":"Eun Joo","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.03.055_bib1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.cdd.4401872","article-title":"Chemotherapy resistance of glioblastoma stem cells","volume":"13","author":"Eramo","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2018.03.055_bib2","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1038\/sj.onc.1208311","article-title":"Isolation of cancer stem cells from adult glioblastoma multiforme","volume":"23","author":"Yuan","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.03.055_bib3","article-title":"Hallmarks of glioblastoma: a systematic review","volume":"1","author":"N\u00f8r\u00f8xe","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.ejmech.2018.03.055_bib4","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1158\/0008-5472.CAN-09-2886","article-title":"Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival","volume":"70","author":"Kang","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2018.03.055_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","article-title":"Trifluoperazine, a well-known antipsychotic, inhibits glioblastoma invasion by binding to calmodulin and disinhibiting calcium release channel IP3R","volume":"16","author":"Kang","year":"2017","journal-title":"Mol. Canc. Ther."},{"key":"10.1016\/j.ejmech.2018.03.055_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib7","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s12094-016-1497-x","article-title":"Survival in glioblastoma: a review on the impact of treatment modalities","volume":"18","author":"Delgado-Lopez","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nm746","article-title":"Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells","volume":"8","author":"Ishiuchi","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2018.03.055_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pathol.1.110304.100043","article-title":"Molecular pathology of malignant gliomas","volume":"1","author":"Louis","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3747\/co.v17i6.574","article-title":"Treatment for glioblastoma multiforme: current guidelines and Canadian practice","volume":"17","author":"Ghose","year":"2010","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib11","first-page":"2585","article-title":"Temozolomide and treatment of malignant glioma","volume":"6","author":"Friedman","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2018.03.055_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejmech.2018.03.055_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140131","article-title":"Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-glycoprotein and CD133 expression","volume":"10","author":"Perazzoli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.03.055_bib14","first-page":"421","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review","volume":"2","author":"Komotar","year":"2008","journal-title":"Clin. Med. Oncol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/cncr.11949","article-title":"Temozolomide in the treatment of recurrent malignant glioma","volume":"100","author":"Chang","year":"2004","journal-title":"Cancer"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejmech.2018.03.055_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.surneu.2008.08.072","article-title":"Radiotherapy followed by adjuvant temozolomide treatment of malignant glioma","volume":"70","author":"Yang","year":"2008","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrn3060","article-title":"The neurobiology of gliomas: from cell biology to the development of therapeutic approaches","volume":"12","author":"Westphal","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2018.03.055_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.03.055_bib19","doi-asserted-by":"crossref","first-page":"170029","DOI":"10.1038\/sdata.2017.29","article-title":"A\u00a0standard database for drug repositioning","volume":"4","author":"Brown","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.ejmech.2018.03.055_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1358\/dnp.2009.22.2.1343228","article-title":"The value of drug repositioning in the current pharmaceutical market","volume":"22","author":"Tobinick","year":"2009","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejmech.2018.03.055_bib21","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2018.03.055_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00873916","article-title":"Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer","volume":"11","author":"Budd","year":"1993","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2018.03.055_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002800050449","article-title":"Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer","volume":"38","author":"Murren","year":"1996","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF00685694","article-title":"Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas","volume":"28","author":"Naftalovich","year":"1991","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.03.055_bib25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/prot.24781","article-title":"Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin","volume":"83","author":"Feldkamp","year":"2015","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2018.03.055_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/1097-0282(20010405)58:4<410::AID-BIP1017>3.0.CO;2-0","article-title":"Molecular dynamics simulation of the calmodulin-trifluoperazine complex in aqueous solution","volume":"58","author":"Yamaotsu","year":"2001","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2018.03.055_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418302988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418302988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T08:03:55Z","timestamp":1719907435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418302988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"alternative-id":["S0223523418302988"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.055","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}